5-BrdU
Cat.No:IB0260 Solarbio
CAS:59-14-3
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥99%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cell Cycle >
5-BrdUCAS:59-14-3
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥99%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 59-14-3 |
Name | 5-BrdU |
Molecular Formula | C9H11BrN2O5 |
Molecular Weight | 307.1 |
Solubility | Soluble in DMSO ≥50mg/mL |
Purity | HPLC≥99% |
Appearance | White to off-white Solid |
Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 200-415-9 |
MDL | MFCD00006529 |
SMILES | OC[C@@H]1[C@H](C[C@H](N2C(NC(C(Br)=C2)=O)=O)O1)O |
InChIKey | WOVKYSAHUYNSMH-RRKCRQDMSA-N |
InChI | InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 |
PubChem CID | 6035 |
Target Point | DNA/RNA Synthesis |
Passage | Cell Cycle;DNA Damage/DNA Repair |
Background | 5-BrdU is a nucleoside analog that competes with thymidine for incorporation into DNA. |
Biological Activity | 5-BrdU是一种核苷类似物,可与胸苷竞争掺入DNA。 5-BrdU通常用于检测增殖细胞。[1-2] |
In Vitro | 溴脱氧尿苷诱导癌细胞系和癌干细胞群扩增RG2大鼠神经胶质瘤细胞的进行性,剂量响应性抑制。在H9细胞和BJ成纤维细胞中,溴脱氧尿苷改变细胞周期谱[1]。 BrdU稳定整合到DNA中,因此可用于评估细胞增殖和其他细胞过程[2]。 |
In Vivo | Bromodeoxyuridine(300 mg/kg,ip或0.8 mg/mL,po)显著减缓大鼠胶质瘤RG2肿瘤模型中的肿瘤进展[1]。 |
Cell Experiment | 最初以2000个细胞/ cm 2接种培养物,并用Z2 Coulter计数器定量。将RG2大鼠神经胶质瘤细胞用0,1,10或50μMBrdU处理24小时,并在18天内获得累积生长曲线。对照和处理的细胞进行定量,并在处理后第5,12和18天以相同的密度重新铺板。 |
Data Literature Source | [1]. Levkoff LH,et al. Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo. Neoplasia. 2008 Aug;10(8):804-16. [2]. Rothaeusler K,et al. Assessment of cell proliferation by 5-bromodeoxyuridine (BrdU) labeling for multicolor flow cytometry. Curr Protoc Cytom. 2007 Apr;Chapter 7:Unit7.31 |
Unit | Bottle |
Specification | 100mg 10mM*1mL in DMSO 500mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Inhibition of mTORC1 signaling protects kidney from irradiation-induced toxicity via accelerating recovery of renal stem-like cells
Click to check >>Author:Shao L; Yang W; Xu R; Zhu S; Huang Y; Li H; Wu X;
IF:8.0790
Publish_to:Stem Cell Res Ther
PMID:30107854
Targeting the mechanism of IRF3 in sepsis-associated acute kidney injury via the Hippo pathway
Click to check >>Author:Xiaomei Chen, Ze Liu, Lingkun Huang, Zhenhua Li, Xingui Dai
IF:5.6000
Publish_to:INTERNATIONAL IMMUNOPHARMACOLOGY
PMID:37441808
Supplementation of n-3 PUFAs in Adulthood Attenuated Susceptibility to Pentylenetetrazol Induced Epilepsy in Mice Fed with n-3 PUFAs Deficient Diet in Early Life
Click to check >>Author:Ying-Cai Zhao; Cheng-Cheng Wang; Xiao-Yue Li; Dan-
IF:5.4000
Publish_to:Marine Drugs
PMID:37367679
IL-17 Inhibits Oligodendrocyte Progenitor Cell Proliferation and Differentiation by Increasing K+ Channel Kv1.3
Click to check >>Author:Liu H; Yang X; Yang J; Yuan Y; Wang Y; Zhang R; Xiong H; Xu Y.
IF:5.3000
Publish_to:Front Cell Neurosci
PMID:34239419
Dl-3-n-Butylphthalide Promotes Remyelination and Suppresses Inflammation by Regulating AMPK/SIRT1 and STAT3/NF-κB Signaling in Chronic Cerebral Hypoperfusion
Click to check >>Author:Li M; Meng N; Guo X; Niu X; Zhao Z; Wang W; Xie X;
IF:4.8000
Publish_to:Front Aging Neurosci
PMID:32581761
Prostaglandin E2 accelerated recovery of chemotherapy-induced intestinal damage by increasing expression of cyclin D
Click to check >>Author:Yue M; Shao L; Cheng J; Fan Y; Cai X; Li H; Li M; Zhang X; Fu A; Huang Y; Nie C; Long F; Chen H; Zhu Q; Zeng H.
IF:3.7000
Publish_to:Exp Cell Res
PMID:31917964
Delayed administration of the glucagon-like peptide 1 analog liraglutide promoting angiogenesis after focal cerebral ischemia in mice
Click to check >>Author:Chen Y; Zhang X; He J; Xie Y; Yang Y.
IF:2.5000
Publish_to:J Stroke Cerebrovasc Dis
PMID:29395648